Acorda Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Acorda Therapeutics's balance sheet done over the years? Its assets were worth $117,745,000 last year, which is less than in the previous period. 234% of Acorda Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $275,701,000, which means an decrease by -9% compared compared to last year.
Debt to Assets
| 2014 | 1080679000 | 540.42M | 50.01% |
|---|---|---|---|
| 2015 | 1116343000 | 513.31M | 45.98% |
| 2016 | 1342335000 | 678.12M | 50.52% |
| 2017 | 1197969000 | 677.98M | 56.59% |
| 2018 | 1299666000 | 687.68M | 52.91% |
| 2019 | 799718000 | 488.89M | 61.13% |
| 2020 | 632680000 | 394.72M | 62.39% |
| 2021 | 455470000 | 304.33M | 66.82% |
| 2022 | 395595000 | 301.97M | 76.33% |
| 2023 | 117745000 | 275.70M | 234.15% |
ACOR Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 30.36M | 37.53M | 45.63M | 71.36M | 62.08M | 293.56M | 307.06M | 158.53M | 153.20M | 182.17M |
Short term investments | 0 | 0 | 0 | 0 | 63.75M | 151.98M | 0 | 0 | 200.10M | 125.44M |
Net receivables | 17.29M | 13.86M | 17.00M | 20.19M | 22.08M | 23.43M | 81.40M | 52.23M | 31.46M | 32.21M |
Inventory | 16.15M | 12.75M | 18.54M | 28.67M | 25.22M | 29.01M | 37.50M | 43.13M | 36.47M | 26.83M |
Other current assets | 10.98M | 11.07M | 7.57M | 16.38M | 15.13M | 30.11M | 15.72M | 18.74M | 30.07M | 42.47M |
Total current assets | 74.79M | 82.11M | 102.15M | 221.33M | 201.11M | 528.10M | 441.69M | 277.05M | 453.44M | 409.13M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 6.3M | 7.89M | 11.13M | 25.74M | 165.97M | 60.51M | 36.66M | 34.31M | 40.20M | 46.09M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 282.05M | 286.61M | 280.59M | 183.63M | 182.95M |
Intangible assets | 22.98M | 305.08M | 335.98M | 366.98M | 402.32M | 428.57M | 430.60M | 742.24M | 430.85M | 432.82M |
Long term investments | 255K | 255K | 6.18M | 18.60M | 30.27M | 0 | 0 | -4.4M | -2.12M | -18.42M |
Other non-current assets | 4.18M | -42.78M | -82.44M | -86.52M | -100.01M | 411K | 2.38M | 8.12M | 8.20M | 9.67M |
Total non-current assets | 42.95M | 313.48M | 353.31M | 411.34M | 598.60M | 771.55M | 756.27M | 1.06B | 662.89M | 671.54M |
Total assets | 117.74M | 395.59M | 455.47M | 632.68M | 799.71M | 1.29B | 1.19B | 1.34B | 1.11B | 1.08B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 227K | 384K | 27.63M | 0 | 0 | 0 | 9.05M | 9.05M | 9.05M | 38.47M |
Short term debt | 187.73M | 1.54M | 8.18M | 76.57M | 8.34M | 616K | 645K | 7.02M | 1.14M | 1.14M |
Total current liabilities | 227.77M | 37.95M | 54.02M | 137.25M | 86.38M | 140.25M | 143.96M | 147.90M | 90.59M | 114.38M |
| Non-current liabilities: | ||||||||||
Long term debt | 3.16M | 171.37M | 182.75M | 183.37M | 241.26M | 343.14M | 334.47M | 324.03M | 295.46M | 287.69M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 35.54M | 48.44M | 53.58M | 53.79M | 96.68M | 196.80M | 153.69M | 80.93M | 73.59M | 63.88M |
Total non-current liabilities | 47.92M | 264.02M | 250.30M | 257.47M | 402.51M | 547.42M | 534.02M | 530.22M | 422.72M | 426.04M |
Total liabilities | 275.70M | 301.97M | 304.33M | 394.72M | 488.89M | 687.68M | 677.98M | 678.12M | 513.31M | 540.42M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |